← Back to Conditions

Spinal muscular atrophy

disorder
SNOMED 5262007CUI C0026847

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Nusinersen

substance

Onasemnogene abeparvovec

substance

Related Conditions

Fazio-Londe syndrome(child)
Distal spinal muscular atrophy(child)
Scapuloperoneal spinal muscular atrophy(child)
Facioscapulohumeral spinal muscular atrophy(child)
Scapulohumeral spinal muscular atrophy(child)
Oculopharyngeal spinal muscular atrophy(child)
Bulbospinal neuronopathy(child)
SMA2(child)
Kugelberg-Welander disease(child)
Werdnig-Hoffmann disease(child)
Adult spinal muscular atrophy(child)
Jankovic-Rivera syndrome(child)
X-linked distal arthrogryposis multiplex congenita(child)
Hamano Tsukamoto syndrome(child)
Autosomal dominant childhood-onset proximal spinal muscular atrophy(child)
Lower motor neuron syndrome with late-adult onset(child)
Autosomal dominant late-onset spinal muscular atrophy Finkel type(child)
Segmental spinal muscular atrophy(child)
Proximal spinal muscular atrophy(child)
Familial motor neuron disease(parent)

Quick Facts

SNOMED CT
5262007
UMLS CUI
C0026847
Fully Specified Name
Spinal muscular atrophy (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
2
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.